Calendar Cyclerion Therapeutics, Inc.

Equities

CYCN

US23255M2044

Delayed Nasdaq 01:06:14 2024-04-25 pm EDT 5-day change 1st Jan Change
3.04 USD +9.75% Intraday chart for Cyclerion Therapeutics, Inc. -13.14% -9.25%

Chart calendar Cyclerion Therapeutics, Inc.

ccf40.xDVfP3ZLuNT3tByecaL5-xVPU8Qa-joHhBQVDuudsuw.tEcdUgYzj4vGxS_aPvSaqUMhDK5FgmBu6yR-Ob7IxbyXBTlnLhrSt5v_JA~371880358b80c08cdf52ea76a92ccb26

Upcoming events on Cyclerion Therapeutics, Inc.

2024-04-30 Q1 2024 Earnings Release (Projected)

Past events on Cyclerion Therapeutics, Inc.

2023-05-15 08:00 am Annual General Meeting
2023-05-11 06:00 pm Q1 2023 Earnings Release
2023-03-22 04:40 pm Q4 2022 Earnings Release
2022-08-09 04:00 pm Interim 2022 Earnings Release
2022-07-28 08:00 am CY6463 MELAS Study Clinical Data Update Call
2022-06-28 08:00 am Business Update Call
2022-06-16 International Conference
2022-06-14 08:00 am Annual General Meeting
2022-06-10 05:30 pm United Mitochondrial Disease Foundation Mitochondrial Medicine Symposium - Panel
2022-06-09 09:00 pm United Mitochondrial Disease Foundation Mitochondrial Medicine Symposium
2022-05-04 04:01 pm Q1 2022 Earnings Release
2021-11-18 03:00 am Jefferies London Healthcare Conference
2021-11-09 04:01 pm Q3 2021 Earnings Release
2021-09-30 02:40 pm Cantor Fitzgerald Global Healthcare Conference
2021-09-13 07:00 am H.C. Wainwright Global Investment Conference
2021-08-26 03:00 pm Biomarkers for Alzheimer Disease Summit - Q&A
2021-08-26 02:30 pm Biomarkers for Alzheimer Disease Summit
2021-08-25 04:20 pm Biomarkers for Alzheimer Disease Summit
2021-07-29 05:00 pm Interim 2021 Earnings Release
2021-07-26 10:00 am Alzheimer Association International Conference - Poster No - P-54463

Annual results

Fiscal PeriodDecember 2019 2020 2021
Net sales
Million USD
Released
Forecast
Spread
4,51
3,50
28.77%
2,30
0,00
-
3,94
4,31
-8.53%
EBITDA
Million USD
Released
Forecast
Spread
-122
-117
-4.38%
-80,6
-81,4
0.91%
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-125
-124
-1.24%
-81,3
-87,0
6.59%
-55,2
-53,7
-2.77%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-123
-122
-1.24%
-77,8
-83,0
6.26%
-51,6
-54,2
4.65%
Net income
Million USD
Released
Forecast
Spread
-123
-122
-0.83%
-77,8
-83,0
6.27%
-51,6
-54,2
4.65%
EPS
USD
Released
Forecast
Spread
-89,8
-99,0
9.27%
-51,2
-32,8
-56.1%
-26,4
-27,6
4.35%
Announcement Date12/03/2025/02/2124/02/22

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3
Net sales
Million USD
Released
Forecast
Spread
0,53
0,90
-40.78%
0,71
0,28
158.55%
0,31
0,36
-13.92%
0,00
0,15
-
EBIT
Million USD
Released
Forecast
Spread
-14,3
-13,3
-7.89%
-13,0
-15,7
17.3%
-13,4
-14,6
7.91%
-10,6
-14,8
28.29%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-10,8
-13,3
18.94%
-13,0
-15,7
17.34%
-13,4
-14,1
5.34%
-10,5
-14,8
28.94%
Net income
Million USD
Released
Forecast
Spread
-10,8
-13,3
18.94%
-13,0
-15,7
17.34%
-13,4
-14,1
5.34%
-10,5
-14,8
28.94%
EPS
USD
Released
Forecast
Spread
-4,72
-6,00
21.29%
-6,00
-7,20
16.67%
-6,20
-6,00
-3.33%
-4,80
-6,20
22.58%
Announcement Date24/02/2204/05/2209/08/2203/11/22

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CYCN Stock
  4. Calendar Cyclerion Therapeutics, Inc.